Continue to site >
Trending ETFs

ELI LILLY AND COMPANY

Stock (NYSE)
LLY
Payout Change
Pending
Price as of:
$746.2 -38.73 0%
Dividend (Fwd)
$5.20
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.70%
LLY: NYSE (Stock)

ELI LILLY AND COMPANY

Payout Change
Pending
Price as of:
$746.2 -38.73 0%
Dividend (Fwd)
$5.20
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.70%
LLY: NYSE (Stock)

ELI LILLY AND COMPANY

$746.2 0%
Dividend (Fwd)
$5.20
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.70%
Payout Change
Pending
Analysis

Name

As of 11/15/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ELI LILLY AND COMPANY

LLY | stock

$746.20

-4.93%

$746 B

0.70%

$5.20

-

Dividend Data
Stock Data
Avg Price Recovery
7.6 Days
Best dividend capture stocks in Nov
Payout Ratio (FWD)
Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. It divides the Forward Annualized Dividend by FY1 EPS. Click here to learn more.
23.09%
Years of Dividend Increase
Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases.
10 yrs
Dividend Frequency
Quarterly
Health Care Avg Yield
1.58%
5 best health care dividend stocks
Market Cap
$746.381 B
Day’s Range
$744.2 - $777.98
Volume
7,334,500
52 Wk Low/High
$561.65 - $972.53
Percent off 52 Wk High
-23.27%
FY1 PE
33.13x
FY1 EPS / Growth
$22.52 / 69.84%

Name

As of 11/15/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ELI LILLY AND COMPANY

LLY | stock

$746.20

-4.93%

$746 B

0.70%

$5.20

-

Ratings - LLY

Dividend Safety

A+

26% payout ratio (sector 36%). Stable.

Yield Attractiveness

D

0.70% forward dividend yield. Bottom 50%.

Returns Risk

A+

0.4 beta (5Y monthly). Diversifier.

Returns Potential

A+

36% price target upside from sell-side analysts. Top 20%.

Quant Recommendation - LLY

Maximize Income Goal

Target

Yields of 7-9%

Horizon

Short

Risk

Moderate-to-high

Retirement Income Goal

Target

Blend low volatility & yield

Horizon

Long

Risk

Low

Monthly Income Goal

Regular payouts for LLY are paid quarterly. Recommendation not provided. See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas.

Growth Goal

Target

Market-beating returns

Horizon

Long

Risk

Moderate

Income & Growth Goal

Target

Blend yield & returns

Horizon

Moderate

Risk

Moderate

Sector Income & Growth Goal

Target

Blend yield & returns in the Health Care sector

Horizon

Long

Risk

Moderate-to-high

LLY Payout History (Paid, Declared and Estimated)

Declared
Paid
Estimated
Year Calendar Year Payout (USD) Calendar Year Payout Growth (USD) Pay Date Declared Date Ex-dividend Date Payout Amount (USD) Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover Yield on Cost
2026e - -
2026-12-08
2026-10-30 2026-11-13 $1.3000 Qualified Regular Quarterly - -
2026-09-08
2026-06-26 2026-08-14 $1.3000 Qualified Regular Quarterly - -
2026-06-09
2026-05-01 2026-05-12 $1.3000 Qualified Regular Quarterly - -
2026-03-10
2025-12-12 2026-02-13 $1.3000 Qualified Regular Quarterly - -
2025e - -
2025-12-08
2025-10-31 2025-11-14 $1.3000 Qualified Regular Quarterly - -
2025-09-08
2025-06-26 2025-08-14 $1.3000 Qualified Regular Quarterly - -
2025-06-09
2025-05-01 2025-05-12 $1.3000 Qualified Regular Quarterly - -
2025-03-10
2024-12-12 2025-02-14 $1.3000 Qualified Regular Quarterly - -
2024e - -
2024-12-10
2024-10-28 2024-11-15 $1.3000 Qualified Regular Quarterly - 0.17%
2024-09-10
2024-06-24 2024-08-15 $1.3000 Qualified Regular Quarterly - 0.14%
2024-06-10
2024-05-06 2024-05-15 $1.3000 Qualified Regular Quarterly - 0.17%
2024-03-08
2023-12-08 2024-02-14 $1.3000 Qualified Regular Quarterly - 0.17%

LLY Dividend Growth CAGR

Dividend Capture Strategy for LLY

Dividend capture strategy is based on LLY’s historical data. Past performance is no guarantee of future results.

Step 1: Buy LLY shares 1 day before the ex-dividend date

Purchase Date

Feb 13, 2025

Upcoming Ex-Dividend Date

Feb 14, 2025

Step 2: SEll LLY shares when price recovers

Sell Date (Estimate)

Feb 22, 2025

Avg Price Recovery

7.6 Days

Avg yield on cost

0.69%

See Full History

News & Research

News

Research

Company Profile

Company Overview

Exchanges: NYSE

Sector: Health Care

Industry: Biotech Pharma

No company description available.

Related Companies

Company Name

Price

Change

% Change

RemeGenix Inc

$4.00

$0.00

0.000%

Regeneus Ltd

$0.00

$0.00

0.000%

Rexahn Pharmaceuticals Inc.

$7.24

-$0.24

-3.209%

Roche Holding AG - ADR

$35.84

-$0.30

-0.830%

RADIUS RECYCLING, INC.

$17.73

$0.38

2.190%

SKYE Life Ventures Ltd

$0.33

-$0.07

-17.500%

Sphere Medical Holding Plc

$0.00

$0.00

0.000%

Stallergenes Greer Plc

$29.62

-$5.33

-15.250%

SQZ Biotechnologies Co

$0.44

$0.17

62.963%

Societal CDMO, Inc.

$1.10

$0.01

0.917%

© 2020&nbsp Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer